Background: Non-communicable diseases such as atherosclerosis are becoming more important as many HIV+ children on ART are reaching school age. Cross-sectional evidence suggests increased prevalence of vascular disease in children on ART after adjustment for traditional atherosclerosis risk factors. This is associated both with advanced HIV disease and with ART itself (particularly lopinavir/ritonavir, LPVr). Aorto-femoral pulse wave velocity (PWV), a measure of arterial elasticity, predicts incident cardiovascular events in asymptomatic adults and is a gold-standard marker of subclinical atherosclerosis. Previous studies in children have focussed on children initiating ART much later than 3 months of age. Our aim was to measure PWV in school children who initiated LPVr-based ART before 3 months of age.
Methods: Cross-sectional PWV and fasted lipid measurements on primary-school-age children who initiated LPVr-based ART in the CHER trial by 3 months of age, with an existing HIV-uninfected control group from the same communities and socio-economic background. Multivariate linear regression to determine the association between PWV and HIV infection.
Results: See table. Unadjusted PWV and growth parameters were similar in the 2 groups. After adjustment for age, gender and body-mass-index-for-age z-score, HIV+ children had adjusted mean total cholesterol 0.7 mmol/L higher than controls (p<0.0001), adjusted mean LDL cholesterol 0.5 mmol/L higher (p=0.001), adjusted mean triglycerides 0.4 mmol/L higher (p<0.0001) and adjusted mean triglyceride to HDL cholesterol ratio 0.3 higher (p<0.0001). However, HIV infection was not associated with differences in PWV after adjustment for age, gender, and systolic blood pressure (p=0.40), despite 80% power to detect a difference as small as 0.3 meters/second.
Conclusions: Despite significantly elevated lipids and prolonged LPVr-based ART exposure, arterial elasticity was no different in HIV+ school-age children and uninfected controls. Early ART may prevent early HIV-related inflammatory vascular damage.
Table 1: Demographics, clinical characteristics and pulse-wave velocity.